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Abstract
Background: Used in conjunction with biological surveillance, behavioural surveillance provides data allowing for a
more precise definition of HIV/STI prevention strategies. In 2008, mapping of behavioural surveillance in EU/EFTA
countries was performed on behalf of the European Centre for Disease prevention and Control.
Method: Nine questionnaires were sent to all 31 member States and EEE/EFTA countries requesting data on the
overall behavioural and second generation surveillance system and on surveillance in the general population,
youth, men having sex with men (MSM), injecting drug users (IDU), sex workers (SW), migrants, people living with
HIV/AIDS (PLWHA), and sexually transmitted infection (STI) clinics patients. Requested data included information on
system organisation (e.g. sustainability, funding, institutionalisation), topics covered in surveys and main indicators.
Results: Twenty-eight of the 31 countries contacted supplied data. Sixteen countries reported an established
behavioural surveillance system, and 13 a second generation surveillance system (combination of biological
surveillance of HIV/AIDS and STI with behavioural surveillance). There were wide differences as regards the year of
survey initiation, number of populations surveyed, data collection methods used, organisation of surveillance and
coordination with biological surveillance. The populations most regularly surveyed are the general population,
youth, MSM and IDU. SW, patients of STI clinics and PLWHA are surveyed less regularly and in only a small number
of countries, and few countries have undertaken behavioural surveys among migrant or ethnic minorities
populations. In many cases, the identification of populations with risk behaviour and the selection of populations
to be included in a BS system have not been formally conducted, or are incomplete. Topics most frequently
covered are similar across countries, although many different indicators are used. In most countries, sustainability of
surveillance systems is not assured.
Conclusion: Although many European countries have established behavioural surveillance systems, there is little
harmonisation as regards the methods and indicators adopted. The main challenge now faced is to build and
maintain organised and functional behavioural and second generation surveillance systems across Europe, to
increase collaboration, to promote robust, sustainable and cost-effective data collection methods, and to harmonise
indicators.
Background
The epidemics attributable to the Human Immunodefi-
ciency Virus (HIV) and to other sexually transmitted
infections (STI) remain a significant public health pro-
blem in Europe. The incidence of HIV infections is not
decreasing, nor is it even stabilized in many populations,
such as men who have sex with men (MSM), injecting
drug users (IDU), or certain migrant populations, such
as persons from Sub-Saharan Africa [1,2]; furthermore,
the reported incidence of several STI is increasing [3-8].
Since the beginning of the HIV/AIDS epidemic, the
importance of monitoring risk behaviour in various tar-
get populations has been recognized and different indi-
cators have been proposed [9]. In the late 1980’s, several
European countries began to collect indicators of beha-
viour in various populations exposed to risk [10-13],
such as MSM [14-17], IDU [18-20], the general popula-
tion [21,22], youth [23] and sex workers (SW) [24,25];
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sively emerged [26,27].
The utility of such behavioural surveillance data in
guiding programme development, especially in conjunc-
tion with biological surveillance data, became apparent
during the 1990’s. The Joint United Nations Programme
on HIV/AIDS (UNAIDS)/World Health Organization
( W H O )h a sd e f i n e ds e c o n dg e n e r a t i o ns u r v e i l l a n c e
(SGS) [28,29] as the «regular, systematic collection, ana-
lysis and interpretation of information for use in track-
ing and describing changes in the HIV/AIDS epidemic
over time». This requires procedures to ensure a com-
bined analysis of both behavioural surveillance (BS) data
and data obtained from biological surveillance of HIV/
AIDS and STI. BS allows for the monitoring of risks
related to transmission of HIV and STI at the popula-
tion level and provides a key source of information not
only to understand the drivers of epidemics, but also for
advocacy and for the planning and evaluation of preven-
tion interventions [30,31]. The type of BS to be con-
ducted, in particular the populations to be included in
the surveillance, depends of the type of HIV epidemic
(generalised, concentrated, low level) [32]. Most Eur-
opean countries have a concentrated type of epidemic
but some have a low-level type.
At the global level, behavioural indicators in various
populations are included in the set of indicators defined
to monitor commitment to the United Nations General
Assembly Special Session on AIDS (UNGASS indica-
tors) [33]. At the European level, the European Monitor-
ing Centre for Drugs and Drug Addiction (EMCDDA)
has proposed a set of core behavioural indicators for use
with IDU [34].
The formalisation and organisation of BS in Europe is
in progress [31,35], but without any review of current
practices having been conducted. There has been little
consideration of behavioural surveillance systems in the
scientific literature [36] and discussion on BS has mainly
appeared only in journal supplements [37-40]. In 2008,
the European Centre for Disease Prevention and Control
(ECDC) therefore commissioned an international team
of experts to produce an in-depth analysis of BS related
to HIV and STI in Europe and to develop a framework
for the implementation of a key set of behavioural indi-
cators. The specific objectives of the study were to pro-
vide an inventory of existing national BS systems and
their functioning in Europe, including identification of
the populations included, and the data collection meth-
ods and indicators used in each system. This article pre-
sents the resultant mapping of BS in Europe, based on a
survey of EU/EFTA countries [41]. Surveillance is exam-
ined at the system level and in the following popula-
tions: general population, youth, IDU, MSM, persons
living with HIV/AIDS (PLWHA), SW, STI clinic clients,
migrants and ethnic minorities.
Methods
An international team of researchers was established
with expertise in behavioural surveys in each of the 8
designated populations. The survey of all EU/EFTA
countries was conducted from June to October 2008.
Information was gathered on: the overall surveillance
system, the specific populations surveyed and the topics
covered and main indicators in use for each population.
The data collection instrument consisted of 9 separate
questionnaires sent to one identified contact person in
each country. One questionnaire concerned the national
behavioural and second generation surveillance system
(s) as a whole, and there were an additional eight ques-
tionnaires covering each of the eight specific population
groups. The questionnaires, provided in word format
using dropdown lists, included both open and closed
questions (see Additional files 1 and 2). In the system-
related questionnaire, information was requested on:
- the existence and definition of a national or regional
BS system(s); indicating which populations were
included and the national key behavioural indicators;
- where in place, the functioning of the second gen-
eration system at national or regional level, including
level of formalisation and documentation, interlinking of
systems, responsibility, financing, analysis, dissemination
and use of results, and sustainability.
In the questionnaires on specific populations, it was
first asked whether a surveillance system was in place
for this population and information was then requested
on the existence of behavioural surveys (or other types
of data collection used for surveillance) conducted since
1985. For each relevant survey (or other type of data
collection) indicated, information was requested on:
- methodology used, including year, sampling method,
data collection method, and main topics covered;
- main indicators followed;
- related publications.
Procedure and analysis
A letter announcing the survey and inviting countries to
participate was sent from the ECDC director to the
directors of the competent bodies for surveillance in the
Member States and to the national ECDC contact
points. The set of 9 questionnaires was then sent by
email to the contact persons responsible for HIV sur-
veillance (as nominated by the ECDC competent bodies
for surveillance) in all EU Member States and European
Free Trade Association (EFTA) countries (n = 31). Indi-
vidual questionnaires could be passed on to the relevant
national specialists for completion; the responsible
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questionnaires.
The returned questionnaires and accompanying mate-
rial were included in a secure online database accessible
only to the international project team. The analysis for
each specific population was conducted according to a
commonly agreed framework by the relevant team
member. The team had regular telephone conferences
during the analysis.
In February 2009, a first draft of the mapping was pre-
sented and discussed at a Behavioural Surveillance Expert
Meeting. Fifty participants, including experts in beha-
vioural surveys in the various populations and experts
from other international organisations (EMCDDA, WHO,
UNAIDS), reviewed and gave advice on the methods and
indicators proposed for each population. A revised draft of
the mapping was then sent for validation to the persons
who had initially collated the questionnaires. Eleven coun-
tries then provided complementary information.
The study collected scientific and administrative meta-
data on the organisation of national behavioural and
second generation surveillance systems, and on the sur-
veys undertaken in this context. As no data was col-
lected on individuals, review by an ethics committee was
not necessary. This study was conducted on behalf of,
and with the approval of the European Centre for
Disease Prevention and Control.
Results
Twenty-eight of the 31 countries surveyed (90%) returned
the questionnaire set; the remaining 3 countries did
not respond within the prescribed deadline (Bulgaria,
Romania, and Portugal; Bulgaria later sent a summary of
its surveillance system in place since 2004, but these data
could not be included in the current analysis). Most ques-
tionnaires were fully completed.
Coverage of behavioural surveillance
Figure 1 gives an overview of existing systems in Europe,
across different countries and populations, with a sum-
mary description of the HIV/STI BS system in each
country. As used here, the term surveillance refers to
data collection through several consecutive surveys. This
may be organised surveillance through repeated surveys
or less organised «systems» based on consecutive data
collections in the same type ofp o p u l a t i o n .I nF i g u r e1 ,
the intensity of the colour in each cell refers to the degree
of establishment of the system and the number refers to
the number of different data collection methods/sources
included in the system for a given population.
Fifteen countries report having an established HIV/STI
BS system (Belgium, Cyprus, Denmark, Estonia, Finland,
France, Germany, Latvia (only for IDU), Lithuania,
Poland, Slovenia, Spain, Sweden, Switzerland, United
Kingdom), and one additional country (the Netherlands)
reports established BS in several specific populations, but
no formal system. The remaining 12 countries report
no BS system. However, in most of these countries,
collection of behavioural data is nonetheless reported
for one or more populations.
There are wide differences among countries as regards
the year of initiation of BS: this extends from 1985
(France: MSM) to the early 2000’s (Poland 2000, Estonia
2004: several populations).
The populations most surveyed are the general popu-
lation (13 countries reporting a system [=Sy]; 4 report-
ing none, but nonetheless conducting surveys or
collecting other type of data [=sv]), youth (Sy: 13; sv: 5),
M S M( S y :1 4 ;s v :4 )a n dI D U( S y :1 7 ;s v :0 ) .W h e r ea
system is in existence, MSM and IDU are the most reg-
ularly surveyed populations. Sex workers (Sy: 6; sv: 2),
patients of STI clinics (Sy: 9; sv: 1) and PLWHA (9
countries report a system, but in 3 of these, no data are
collected on risk behaviour) are less surveyed, and few
countries report having undertaken BS among migrant
or ethnic minority populations (3 countries with a
reported system; 2 with planned BS).
In most countries and populations, BS relies on one or
two data collection sources per population. In some
countries, however, more sources are used. For example,
the UK reports relying on five ongoing surveillance sur-
veys among MSM. When a population is difficult to
reach, a diversity of sources may be used. Hence, in
Switzerland, specific questions on «paying for sex» or
«being paid for sex» are included in surveys among the
general population, MSM and IDU. Similarly, a diversity
of recruitment sites and populations surveyed is adopted
in BS among migrants in the Netherlands. Spain obtains
data on youth through surveying a diversity of age
groups and collecting data from surveys with different
focal points, such as sexuality, general health, or drugs.
Completeness of Systems
Since the start of the HIV/AIDS epidemic, several
Western European countries with early concentrated
epidemics have conducted behavioural surveys in order
to identify risk behaviour and monitor progress in pre-
vention. These have taken place in a number of different
populations, essentially in the general population, youth,
MSM and IDU. In some countries or regions, these sur-
veys were undertaken and repeated with the intention of
constituting a coherent BS system. Switzerland and Cat-
alonia in Spain have such long-term integrated systems.
In other countries, the «system» was constructed pro-
gressively, with the addition of new surveyed popula-
tions over time. Although the surveys were sometimes
analysed together as a periodic review exercise, there
was not always a clear surveillance objective. France,
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generally have such established surveillance in four or
more populations, but this activity is not coordinated
into a system.
In Eastern European countries with recent concen-
trated epidemics, mainly in IDU (such as Estonia,
Lithuania, Latvia), formal comprehensive systems have
been set up recently, using from the outset the concept
of second generation surveillance. This has often
involved the collaboration and funding of international
agencies. These systems mainly include small-scale
surveys in 2-4 populations.
In the other countries (Belgium, Cyprus, Denmark,
Finland, Latvia, Slovenia, Spain and Sweden), systems
were established during the 1990 s, and include national
and regional/local surveillance and/or a small number of
populations.
Even in countries with formalised or long established
BS, there is often no established regularity in the timing
of BS in the different populations, possibly indicating
instability of the system. For example, in some Western
European countries, surveysi nt h eg e n e r a lp o p u l a t i o n
and MSM were conducted more frequently at the begin-
ning of the AIDS epidemic than during recent years.
Consequently, the term «system» does not necessarily
imply data collection at regular intervals.
Organisation and functioning of BS
The degree of formalisation of BS within a system is very
unequal across the different countries (Table 1). Among
the 16 countries reporting or having de facto BS, only
8 declared the existence of a document describing this
system or formalising its existence: Cyprus, Estonia,
Latvia, Lithuania, Poland, Switzerland and United King-
dom. Most of these countries have recent, concentrated
HIV epidemics. The system is generally mentioned in the
national strategic HIV/AIDS plan or in the Monitoring &
Evaluation Plan (M&E plan).
The organisation of BS also shows diversity. In coun-
tries with formalised BS, its organisation and coordina-
tion is based in the Ministry of Health (MOH) (e.g.
Lithuania), or in a National Health Agency (e.g. Estonia),
or, in one case, in a university (Switzerland). In coun-
tries with less formalised systems, coordination occurs
through a network of institutions: government agencies,
universities, NGO’s (e.g. United Kingdom, France).
In Western Europe, the government is generally the
main source of funding for BS. In certain cases, addi-
tional resources come from research. A few countries
cite international agencies, such as the Global Fund on
AIDS, Tuberculosis and Malaria (GFATM), as partners
in the funding of BS.
Twelve of the sixteen countries with established BS
report that sustainability is assured or probably assured.
Sustainability and cost are the main problems men-
tioned by countries regarding BS.
Second generation surveillance (SGS)
Among the 16 countries reporting BS, 13 also report the
existence of SGS. Two additional countries report SGS
in one population: Latvia (in the IDU population) and
Sweden (in the general population).
Six countries (Estonia, France, Lithuania, Slovenia,
Spain, and Switzerland) report a formalised BS system,
with a management or coordinating body, organised in
one of two different ways:
- management by MOH or by a governmental agency,
with collection and synthesis of information from
diverse sources and production and dissemination of
reports;
- coordination by MOH of discussion of SGS results
by a group of diverse stakeholders, including agencies/
universities producing the data, MOH representatives
(epidemiology, prevention, evaluation) and AIDS NGO’s.
Five countries report having a SGS system that is not
formally organised: in Germany, the Netherlands and
the United Kingdom, SGS is carried out by a network of
institutions without centralised coordination. Reports
are produced regularly (The Netherlands); their produc-
tion and dissemination may be left to the individual
institutions (United Kingdom).
In countries reporting SGS, data seem to be used for a
variety of purposes, with different audiences in mind.
The three most frequent uses are: interpreting trends in
HIV incidence and prevalence, identifying the drivers of
the epidemic and measuring indicators of progress in
programme development. SGS is less used in programme
planning, in projecting future interventions or as an
advocacy tool to increase resources and expand response.
Methods used for behavioural surveillance in the
different populations
Table 2 shows the methods used for BS in the different
populations. For the general population and youth, sur-
veillance is based on surveys in a representative sample
of the population. A mix of data collection methods/
sources was in use in several countries (e.g. comprehen-
sive sexuality surveys conducted at long intervals comple-
mented by more regularly conducted KABP). Questions
on sexuality included in general health surveys are the
main surveillance mode in use for young people, this
population being either specifically surveyed or included
as a subsample of the general population.
There is a long tradition of MSM surveillance in Europe.
Internet surveys are progressively replacing or comple-
menting venue-based surveys; respondent driven sampling
(RDS) has recently been used in countries where MSM are
still difficult to reach (Estonia, Greece).
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behavioural surveillance (n = 16)
Behavioural surveillance system Second generation system
Formalisation in
documents
Organisation Existing Formal Management/coordination body and
functioning
Belgium No Informal, mix of national and regional
repeated or small scale one/off studies
No - -
Cyprus HIV/AIDS
strategic plan
No management/coordination body Yes, partly Yes Information from BS and biological systems is
analysed and interpreted informally by
program officials. A recent report on period
1986-2007 has been produced
Denmark No Surveillance only in MSM No
Estonia M&E system,
national AIDS
strategic plan
Coordination by a government agency Yes Yes Separate bodies for behavioural and
biological surveillance, coordination by the
National Institute for Health Development
Agency with centralised production and
dissemination of reports
Finland No Under the responsibility of a government
agency
No - Under the responsibility of the National
Public Health Institute
France No No centralized body: various national
agencies (surveillance, research, prevention)
and other institutions are involved
inbehavioural surveillance.
Yes No Coordination by the Institut de Veille Sanitaire
(InVS). Reports or syntheses of studies are
issued periodically
Germany No Informal coordination between the Federal
Ministry of Health, a health agency and
research institutions
Yes, partly No Organised informally by a network of
institutions
Latvia Regulation for
registration of
infectious diseases
Under the responsibility of a government
agency
Yes, for
IDU only
Yes Under the responsibility of the Public Health
Agency
Lithuania National AIDS
programme and
Resolution on STI
surveillance
Under the responsibility of the Ministry of
Health (MOH)
Yes, partly Yes Management by the MOH
Netherlands No No centralised body: cooperation between
the National Institute for Public Health and
the Environment and the HIV/STIs Agency
Yes, partly Yes Cooperation within a network of institutions;
reports are issued regularly
Poland National programs
on AIDS and on
addictions
No centralized coordination, collaboration
between agencies
Yes partly Yes Information comes from different sources,
and is sometimes, but not routinely, used to
interpret the epidemiological situation.
Reports are published on the government
site
Slovenia Institute of Public
Health internal
protocols
Under the responsibility of the Institute of
Public Health of the Republic of Slovenia
Yes Yes Institute of Public Health is responsible for
the analysis, interpretation and dissemination
of SGS information to many audiences (MOH,
media, professionals, population)
Spain HIV multisectoral
plan
Under the responsibility of the Secretariat
of the National Plan on AIDS, Ministry of
Health
Yes Yes The Secretariat of the National Plan on AIDS
collects and publishes available information
Sweden No Under the responsibility of a government
agency of the National Board for Health
and Welfare
Yes, for
general
population
- Collaboration within a network of institutions;
summary reports are produced by the
National Board of Health and Welfare for the
government, and then sent to all health
authorities in the country
Switzerland National AIDS
program,
protocols
Under the responsibility of the University
Institute of Social and Preventive Medicine
and financed by the Federal Office of
Public Health
Yes Yes Coordination is assumed by the Federal
Office of Public Health (FOPH). All information
pertaining to SGS is presented and discussed
in a special working group-including FOPH,
non-governmental organisations, partners
from biological and behavioural surveillance.
Reports are issued periodically
UK Scientific article No centralized body. Data produced by a
network of agencies.
Yes, partly Yes No central coordination and dissemination of
data; this is left to individual institutions and/
or research groups to synthesise and publish
Mapping of HIV/STI behavioural surveillance in Europe, 2008.
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from those in contact with services, either through rou-
tine collection of assessment data on those entering
treatment or through cross-sectional surveys of those in
contact with a range of health or social services, such as
needle exchanges and drop-in centres. A small number
of community-based surveys have been conducted using
a range of methods.
In sex workers, surveillance is mainly service-or
venue-based. Several countries also use data collected in
other populations, such as MSM or IDU, and two coun-
tries use data on sex worker clients collected in general
population surveys.
In PLWHA, services and venues are also the main
recruitment sites, and surveys in specific populations
(IDU and MSM) are also used for surveillance of
PLWHA in these populations. Cohorts are used for BS in
2 countries.
For migrants, where established surveillance is rare,
general population surveys with questions on nationality
or country of origin, allowing for identification of
migrants, and/or community-based surveys are the main
sources of data. The mapping exercice also revealed the
extent to which different terms and concepts are used
to refer to «migrants».
For STI clinic patients, surveillance is, by definition,
service-based and relies on either routinely collected
data or point prevalence surveys.
Indicators
Analysis of topics covered in the various surveys showed
much convergence across countries and across popula-
tions on the most important indicators, even if the degree
of formulation is still uneven. Harmonisation has taken
place in certain populations (in IDU with EMCDDA indi-
cators, in MSM through different initiatives [42]) and,
more generally, through the UNGASS reporting process.
However, there is still enormous variation between coun-
tries in the specific indicators used with regard to content
and wording, reference period used, and so on. To illus-
trate, in young people, 11 different indicators of condom
u s ew e r ei d e n t i f i e d ,i n c l u d ing condom use at last sexual
intercourse, condom use at last intercourse among those
who had more than one partner in the last 12 months,
condom use with steady partner, condom use in sponta-
neous sexual contact, condom use in new relationships.
In order to further the harmonisation process, five core
indicators have been proposed that are common to all
populations. These are coherent with existing international
recommendations and cover:
- the number of sexual partners in the last 12 months
- condom use at last intercourse (in the last 12 months)
with the identification-in a consecutive question-of the
type of partner with whom the last intercourse took
place (stable, casual, or paid)
- experience of HIV testing, constructed on the basis
of three questions (ever tested, date and result of the
last test)
- sex work: having paid for sex in the last 12 months
and use of condom at last paid sex
- a composite indicator of knowledge (UNGASS indi-
cator number 13).
A common set of socio-demographic indicators are
also proposed: level of education, nationality or ethnic
origin and sexual orientation.
Discussion
Europe is rich in expertise and experience in beha-
vioural studies related to HIV and STI, especially among
MSM, IDU, the general population and youth. In many
countries, there has been a progressive accumulation of
surveys or other types of data collection constituting,
Table 2 Methods used in behavioural surveillance: number of countries using as main method(s)
General
Population
Youth MSM IDU SW STI
patients
PLWHA Migrants
Representative designs
Sexuality module in general health surveys 6 14 2 2
Specific KABP survey 8 10
Comprehensive sexuality/reproductive health surveys 8 6 1
Addiction focused surveys 2 5
Surveys using respondent driven sampling for hard-to-reach populations 2 2 1
Non representative designs
Service based data collection 11 5 9 3 1
Internet surveys 1 14 2
Venue-based/community based surveys 12 8 4 3 5
Cohort studies 2
Mapping of HIV/STI behavioural surveillance in Europe, 2008.*
* More than one method may be used for surveillance in a population.
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However, even when the material is available, the con-
certed organisation of this into a formal, comprehensive
and sustainable system has only taken place in a limited
number of cases. This is particularly true as regards
second generation systems, a significant part of which
have only a low level of fomalisation and a moderate
level of dissemination and use. This is reflected in the
paucity of published articles and of available reports on
BS systems; data on behaviour in specific populations
being more frequently the object of publications.
Movement towards simplification of data collection is
noticeable in various populations, as exemplified by the
increased use of internet-based surveys in MSM, ser-
vice-based data collection in IDU, and in the use of gen-
eral health surveys to collect data on sexual behaviour
and drug use in the general population and in youth.
These newer approaches offer advantages in terms of
sustainability and cost provided that comparison over
time can be maintained.
In MSM and IDU, where there is the longest experi-
ence of BS, the length and robustness of trends and the
relatively low cost of non-probablistic methods of sam-
pling (venue-, internet- or service-based) can explain the
paucity of experience with RDS and the probable reluc-
tance to adopt this recently promoted method for BS in
these populations [43]. Favouring less costly data collec-
tion methods over RDS would seem a reasonable choice
in the case of mature epidemics.
It is not easy to evaluate the adequacy of BS in European
countries: in many cases the identification of populations
with risk behaviour and the selection of populations to be
included in a BS system has not been formally defined, or
is incomplete. Several gaps may nevertheless be identified:
￿ Some countries still have no data on MSM or IDU.
Very few countries have collected data on sex workers
and migrants, two populations difficult to reach and/or
to identify reliably, and practically none has BS installed
on a long-term basis. Few BS systems are in place in
populations that are clearly identified as potentially at-
risk of acquiring or transmitting infections and accessi-
ble through the health system, such as STI patients and
PLWHA.
￿ In several countries, the formalisation and function-
ing of the system and its use are less developed than
might be expected, given the opportunities.
There are many challenges regarding the future of BS
in Europe:
One of the challenges in the years to come will be to
reinforce or maintain BS. Europe, particularly Western
Europe, faces a decrease in the level of priority accorded
to HIV (for example, in reaction to potential new epi-
demics, such as AH1N1), with a consequent decrease in
the availability of funding for HIV prevention and
research, including behavioural surveys. In certain East-
ern European countries, international funding provided
to initiate surveillance is decreasing. The necessity of
maintaining BS may be challenged. Yet, there are many
reasons to maintain BS in the Europe:
- As mentioned above, the epidemiological situation
regarding HIV and other STI is worsening in many
countries. In addition, there is a continuous increase in
the pool of HIV infected people.
- A decrease in the use of protection and the develop-
ment of alternative HIV/STI-related patterns of beha-
viour (risk reduction, stopping condom use under
certain treatment conditions [44]) has begun to appear
and deserves close monitoring.
- There are concerns regarding access to prevention
and care, especially for marginalised populations, such
as certain categories of migrants [45] and IDU [46]; BS
could be used for planning interventions and advocating
for resources.
- The sustainability of existing systems is not always
guaranteed.
The cost of BS is one element threatening sustainability.
Attempts have been made to reduce costs, while maintain-
ing the availability of valid and reliable behavioural trends,
and may serve as examples. These include: use of internet
(MSM) and service-based surveillance (wherever possible);
increased collaboration with existing PLWHA cohorts;
insertion of sexuality modules in general health surveys
replacing KAPB surveys; use of proxy data, such as infor-
mation on SW obtained from clients in general population
surveys.
The frequency of data collection should also be recon-
sidered. In several populations, such as the general
population and youth, intervals between data collection
may extend to 4-6 years, while in populations with
higher HIV incidence, shorter intervals and more flex-
ibility are needed. Qualitative studies may also be used
to provide information on developments in specific
populations and to facilitate decisions regarding the
necessity of conducting surveys.
Our study has some limitations. The information
delivered by the questionnaire was self-reported and the
responses varied greatly as regards the level of detail
included in the description of systems. The person to
whom the questionnaire set was sent in each country
was the ECDC contact person at national level for HIV
biological surveillance; there is currently no specific
ECDC contact person for behavioural surveillance. This
person may have been unaware of the existence of sur-
veys in some or all populations of interest, whether
organised or not in a behavioural surveillance system,
and may have given inadequate answers or may not
have passed the population-specific questionnaires to
the relevant national specialists. This would result in
Dubois-Arber et al. BMC Infectious Diseases 2010, 10:290
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unlikely that any organised national behavioural surveil-
lance would be unknown to the ECDC contact person.
Furthermore, this survey was launched with a letter
from the ECDC director, thus indicating a high level of
importance. The report was also circulated to countries
for validation, offering a further occasion for verification.
Few original questionnaires used for surveillance were
sent by the countries. Nevertheless, most countries sent
useful complementary information, such as references to
documents or publications describing their systems.
Conclusions
The main challenge now faced is to build and maintain
organised and functional behavioural and second gen-
eration surveillance systems at national level, with the
following characteristics. First, there should be a regular
assessment of the appropriateness and quality of the sys-
tem. Second, a designated body should be set up, with
clear responsibility for data coordination, collection,
analysis and dissemination. This body should be quali-
fied to make decisions regarding the simplification or
extension of the system, on the basis of epidemiological
and behavioural trends, cost, sustainability, quality and
robustness of the system.
Additional material
Additional file 1: questionnaire related to behavioural surveillance
in the general population. This questionnaire collects information on
the existence and the characteristics of behavioural surveillance
conducted in the general population in a given country.
Additional file 2: questionnaire related to the behavioural
surveillance system. This questionnaire collects information on the
existence and the characteristics of the behavioural surveillance system
as a whole in a given country.
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